Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus

In patients with HIV infection and base-line CD4 counts above 200 cells per cubic millimeter, intermittent infusions of interleukin-2 produced substantial and sustained increases in CD4 counts with no associated increase in plasma HIV RNA levels.